Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: First thing JT said when named Pres/CEO

First thing JT said when named Pres/CEO

posted on Feb 29, 2008 11:56AM

<We're now ready for a more product-focused strategy to complement the ongoing licensing strategy of our valuable patent portfolio. My plan is to convert our technology and equity into a sustainable product line that will grow over time. Through a combination of in-house efforts and strategic acquisition, I expect to pursue exciting market opportunities in consumer, automotive, and industrial sectors. There are exciting days ahead for our customers and shareholders," concluded Turley. >

I would think M&A is not panning out the way he had hoped. That phrase I underlined could be the problem.

One must recognize that management is sitting on quite a bunch of options/shares that they would love to cash in soon for some nice $$$. Perhaps M&A is not seen as improving the pps fast enough. If so, what is plan B? Opty

Share
New Message
Please login to post a reply